ChromoGenics

Mindre end 1K følgere

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Selskabsmeddelelse16.9.2024, 14.45

Avnotering av ChromoGenics AB (publ) från Nasdaq First North Stockholm

Selskabsmeddelelse30.8.2024, 06.30

ChromoGenics AB (publ): ChromoGenics Interim Report January-June 2024

Selskabsmeddelelse25.6.2024, 11.45

ChromoGenics AB (publ): Bulletin from the annual general meeting held on 25 June 2024

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Selskabsmeddelelse18.6.2024, 14.30

ChromoGenics AB (publ) publishes the Annual Report for 2023

Selskabsmeddelelse30.5.2024, 11.00

ChromoGenics AB (publ): ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant

Selskabsmeddelelse24.5.2024, 07.00

ChromoGenics AB (publ): NOTICE TO ANNUAL GENERAL MEETING IN CHROMOGENICS AB

Selskabsmeddelelse23.5.2024, 06.30

ChromoGenics AB (publ): Interim Report January - March 2024

Selskabsmeddelelse8.4.2024, 17.00

ChromoGenics AB (publ): ChromoGenics announces new date for its annual general meeting and annual report 2023

Selskabsmeddelelse5.4.2024, 13.30

ChromoGenics AB (publ) announces allocation in directed share issue

Selskabsmeddelelse5.4.2024, 09.45

ChromoGenics AB (publ): Bulletin from the Extraordinary General Meeting on 5 April 2024

Selskabsmeddelelse2.4.2024, 17.00

ChromoGenics AB (publ): ChromoGenics receives first order for North America

Selskabsmeddelelse25.3.2024, 11.00

ChromoGenics AB (publ): ChromoGenics initiates cost reduction program

Pressemeddelelse11.3.2024, 06.55

Redeye: ChromoGenics - Entering 2024 with the ambitious Skanska collaboration in focus

Selskabsmeddelelse8.3.2024, 07.30

ChromoGenics AB (publ): Year-End Report January 1- December 31, 2023

Selskabsmeddelelse6.3.2024, 08.10

ChromoGenics AB (publ): NOTICE TO EXTRAORDINARY GENERAL MEETING IN CHROMOGENICS AB (PUBL)

Selskabsmeddelelse5.3.2024, 20.40

ChromoGenics AB (publ): CHROMOGENICS HAS SUCCESSFULLY COMPLETED A DIRECTED SHARE ISSUE OF APPROXIMATELY SEK 16 MILLION

Selskabsmeddelelse5.3.2024, 16.31

ChromoGenics AB (publ): Chromogenics evaluates the conditions for carrying out a directed issue of shares

Pressemeddelelse19.2.2024, 09.40

ChromoGenics AB (publ): ChromoGenics' Dynamic Glass in Boverket's New Headquarters

Selskabsmeddelelse16.2.2024, 15.00

ChromoGenics AB (publ): ChromoGenics communicates order data for the fourth quarter in 2023 and postpones publication of the year-end report for 2023.

Pressemeddelelse5.12.2023, 12.00

ChromoGenics AB (publ): ChromoGenics will deliver Dynamic Glass to an office building in Sweden

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.